Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Mar;91(3):838–844. doi: 10.1172/JCI116304

Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.

M Edery 1, M Rozakis-Adcock 1, L Goujon 1, J Finidori 1, C Lévi-Meyrueis 1, J Paly 1, J Djiane 1, M C Postel-Vinay 1, P A Kelly 1
PMCID: PMC288035  PMID: 8450064

Abstract

A single point mutation in the growth hormone (GH) receptor gene generating a Phe-->Ser substitution in the extracellular binding domain of the receptor has been identified in one family with Laron type dwarfism. The mutation was introduced by site-directed mutagenesis into cDNAs encoding the full-length rabbit GH receptor and the extracellular domain or binding protein (BP) of the human and rabbit GH receptor, and also in cDNAs encoding the full length and the extracellular domain of the related rabbit prolactin (PRL) receptor. All constructs were transiently expressed in COS-7 cells. Both wild type and mutant full-length rabbit GH and PRL receptors, as well as GH and prolactin BPs (wild type and mutant), were detected by Western blot in cell membranes and concentrated culture media, respectively. Immunofluorescence studies showed that wild type and mutant full-length GH receptors had the same cell surface and intracellular distribution and were expressed with comparable intensities. In contrast, all mutant forms (full-length receptors or BPs), completely lost their modify the synthesis ligand. These results clearly demonstrate that this point mutation (patients with Laron syndrome) does not modify the synthesis or the intracellular pathway of receptor proteins, but rather abolishes ability of the receptor or BP to bind GH and is thus responsible for the extreme GH resistance in these patients.

Full text

PDF
838

Images in this article

840Image
on p.840
840Image
on p.840
841Image
on p.841
841Image
on p.841
841Image
on p.841
841Image
on p.841
841Image
on p.841
841Image
on p.841

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amselem S., Duquesnoy P., Attree O., Novelli G., Bousnina S., Postel-Vinay M. C., Goossens M. Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med. 1989 Oct 12;321(15):989–995. doi: 10.1056/NEJM198910123211501. [DOI] [PubMed] [Google Scholar]
  2. Amselem S., Sobrier M. L., Duquesnoy P., Rappaport R., Postel-Vinay M. C., Gourmelen M., Dallapiccola B., Goossens M. Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism. J Clin Invest. 1991 Mar;87(3):1098–1102. doi: 10.1172/JCI115071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bass S. H., Mulkerrin M. G., Wells J. A. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4498–4502. doi: 10.1073/pnas.88.10.4498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bass S., Wells J. Growth hormone-receptor gene in Laron dwarfism. N Engl J Med. 1990 Mar 22;322(12):854–855. doi: 10.1056/NEJM199003223221218. [DOI] [PubMed] [Google Scholar]
  5. Baumann G., Shaw M. A., Winter R. J. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. J Clin Endocrinol Metab. 1987 Oct;65(4):814–816. doi: 10.1210/jcem-65-4-814. [DOI] [PubMed] [Google Scholar]
  6. Daughaday W. H., Trivedi B. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci U S A. 1987 Jul;84(13):4636–4640. doi: 10.1073/pnas.84.13.4636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Duquesnoy P., Sobrier M. L., Amselem S., Goossens M. Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10272–10276. doi: 10.1073/pnas.88.22.10272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edery M., Jolicoeur C., Levi-Meyrueis C., Dusanter-Fourt I., Pétridou B., Boutin J. M., Lesueur L., Kelly P. A., Djiane J. Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2112–2116. doi: 10.1073/pnas.86.6.2112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Godowski P. J., Leung D. W., Meacham L. R., Galgani J. P., Hellmiss R., Keret R., Rotwein P. S., Parks J. S., Laron Z., Wood W. I. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8083–8087. doi: 10.1073/pnas.86.20.8083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hocquette J. F., Postel-Vinay M. C., Djiane J., Tar A., Kelly P. A. Human liver growth hormone receptor and plasma binding protein: characterization and partial purification. Endocrinology. 1990 Oct;127(4):1665–1672. doi: 10.1210/endo-127-4-1665. [DOI] [PubMed] [Google Scholar]
  11. Hocquette J. F., Postel-Vinay M. C., Kayser C., de Hemptinne B., Amar-Costesec A. The human liver growth hormone receptor. Endocrinology. 1989 Oct;125(4):2167–2174. doi: 10.1210/endo-125-4-2167. [DOI] [PubMed] [Google Scholar]
  12. Kelly P. A., Djiane J., Postel-Vinay M. C., Edery M. The prolactin/growth hormone receptor family. Endocr Rev. 1991 Aug;12(3):235–251. doi: 10.1210/edrv-12-3-235. [DOI] [PubMed] [Google Scholar]
  13. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Laron Z., Pertzelan A., Karp M., Kowadlo-Silbergeld A., Daughaday W. H. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab. 1971 Aug;33(2):332–342. doi: 10.1210/jcem-33-2-332. [DOI] [PubMed] [Google Scholar]
  16. Laron Z., Pertzelan A., Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism? Isr J Med Sci. 1966 Mar-Apr;2(2):152–155. [PubMed] [Google Scholar]
  17. Lesueur L., Edery M., Ali S., Paly J., Kelly P. A., Djiane J. Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):824–828. doi: 10.1073/pnas.88.3.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Leung D. W., Spencer S. A., Cachianes G., Hammonds R. G., Collins C., Henzel W. J., Barnard R., Waters M. J., Wood W. I. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 1987 Dec 10;330(6148):537–543. doi: 10.1038/330537a0. [DOI] [PubMed] [Google Scholar]
  19. Louvard D., Reggio H., Warren G. Antibodies to the Golgi complex and the rough endoplasmic reticulum. J Cell Biol. 1982 Jan;92(1):92–107. doi: 10.1083/jcb.92.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  21. Posner B. I., Bergeron J. J., Josefsberg Z., Khan M. N., Khan R. J., Patel B. A., Sikstrom R. A., Verma A. K. Polypeptide hormones: intracellular receptors and internalization. Recent Prog Horm Res. 1981;37:539–582. doi: 10.1016/b978-0-12-571137-1.50016-5. [DOI] [PubMed] [Google Scholar]
  22. Postel-Vinay M. C., Belair L., Kayser C., Kelly P. A., Djiane J. Identification of prolactin and growth hormone binding proteins in rabbit milk. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6687–6690. doi: 10.1073/pnas.88.15.6687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Reggio H., Webster P., Louvard D. Use of immunocytochemical techniques in studying the biogenesis of cell surfaces in polarized epithelia. Methods Enzymol. 1983;98:379–395. doi: 10.1016/0076-6879(83)98166-1. [DOI] [PubMed] [Google Scholar]
  24. Rozakis-Adcock M., Kelly P. A. Identification of ligand binding determinants of the prolactin receptor. J Biol Chem. 1992 Apr 15;267(11):7428–7433. [PubMed] [Google Scholar]
  25. Smith W. C., Talamantes F. Gestational profile and affinity cross-linking of the mouse serum growth hormone-binding protein. Endocrinology. 1988 Sep;123(3):1489–1494. doi: 10.1210/endo-123-3-1489. [DOI] [PubMed] [Google Scholar]
  26. Tar A., Hocquette J. F., Souberbielle J. C., Clot J. P., Brauner R., Postel-Vinay M. C. Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration. J Clin Endocrinol Metab. 1990 Nov;71(5):1202–1207. doi: 10.1210/jcem-71-5-1202. [DOI] [PubMed] [Google Scholar]
  27. Ymer S. I., Herington A. C. Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum. Mol Cell Endocrinol. 1985 Jul;41(2-3):153–161. doi: 10.1016/0303-7207(85)90018-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES